Résistance hormonale, méthylation et cancer du sein - CRCL
By A Mystery Man Writer
Description
Novel Genetic and Epigenetic Biomarkers of Prognostic and Predictive Significance in Stage II/III Colorectal Cancer - ScienceDirect
CRCL Centre de Recherche en Cancérologie de Lyon sur LinkedIn : Cancer du sein : vers une meilleure prise en charge des patientes traitées…
Candidate methylation sites associated with endocrine therapy resistance in ER+/HER2- breast cancer, BMC Cancer
Ludivine Pruvost sur LinkedIn : AVANCÉE DANS LA RECHERCHE DU CANCER DU SEIN
DNA Methylation and Anticancer Drug Resistance in Gynecological Tumors
Role of epigenetics in transformation of inflammation into colorectal cancer
Role of cellular reprogramming and epigenetic dysregulation in acquired chemoresistance in breast cancer
Androgen receptor gene methylation related to colorectal cancer risk in: Endocrine Connections Volume 8 Issue 7 (2019)
Drug resistance in colorectal cancer: An epigenetic overview - ScienceDirect
Publications - Page 44 of 146 - CRCL
Nuclear PRMT5 is a biomarker of sensitivity to tamoxifen in ERα+ breast cancer
from
per adult (price varies by group size)